Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes
Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This pilot trial seeks to gather preliminary data on the combination of chromium picolinate,
the most commonly used form of chromium, and metformin. The trial will recruit type 2
diabetes subjects already on metformin and treat them with chromium for 8 weeks. The results
of this trial will provide vital preliminary data including safety and size of effect to
direct future studies.